The University of Chicago Header Logo

Connection

Diarmuid Moran to Pyrazines

Back to Details
This is a "connection" page, showing publications Diarmuid Moran has written about Pyrazines.
Diarmuid Moran
Connection Strength
0.142
Pyrazines
  1. A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations. Clin Cancer Res. 2017 Dec 15; 23(24):7467-7473.
    View in: PubMed
    Score: 0.142
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.